- Nachrichtendetail
-
03.07.2024 14:04:13 - dpa-AFX: *J&J : HEALTH CANADA AUTHORIZES RYBREVANT COMBINATION FOR EGFR EXON 20 NON-SMALL CELL LUNG CANCER
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Johnson & Johnson | 853260 | NYSE | 149,381 | 11.07.24 21:00:36 | -0,049 | -0,03% | 149,350 | 149,390 | 149,580 | 149,430 |
